No abstract available
MeSH terms
-
Acquired Immunodeficiency Syndrome / chemically induced
-
Age Factors
-
Ataxia Telangiectasia / drug therapy*
-
Ataxia Telangiectasia / metabolism
-
Ataxia Telangiectasia / physiopathology
-
Ataxia Telangiectasia Mutated Proteins
-
Betamethasone / adverse effects
-
Betamethasone / therapeutic use*
-
Cell Cycle Proteins / genetics
-
Cerebellum / metabolism
-
Cerebellum / pathology
-
Cerebellum / physiopathology
-
Clinical Trials as Topic / statistics & numerical data
-
DNA-Binding Proteins / genetics
-
Glucocorticoids / adverse effects
-
Glucocorticoids / therapeutic use*
-
Humans
-
Immunosuppression Therapy / adverse effects
-
Immunosuppression Therapy / methods
-
Oxidative Stress / drug effects
-
Oxidative Stress / physiology
-
Protein Serine-Threonine Kinases / genetics
-
Risk Assessment
-
Time
-
Time Factors
-
Treatment Outcome
-
Tumor Suppressor Proteins / genetics
Substances
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Glucocorticoids
-
Tumor Suppressor Proteins
-
Betamethasone
-
ATM protein, human
-
Ataxia Telangiectasia Mutated Proteins
-
Protein Serine-Threonine Kinases